iShares Biotechnology ETF (NASDAQ:IBB) Shares Bought by James J. Burns & Company LLC

James J. Burns & Company LLC lifted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 15.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,361 shares of the financial services provider’s stock after buying an additional 310 shares during the quarter. James J. Burns & Company LLC’s holdings in iShares Biotechnology ETF were worth $311,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in IBB. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $29,000. Highline Wealth Partners LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth approximately $30,000. HHM Wealth Advisors LLC raised its stake in iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in iShares Biotechnology ETF in the 3rd quarter valued at $36,000. Finally, Modus Advisors LLC acquired a new stake in iShares Biotechnology ETF during the 4th quarter worth $41,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.6 %

iShares Biotechnology ETF stock opened at $137.85 on Tuesday. The company has a fifty day simple moving average of $136.33 and a 200-day simple moving average of $141.50. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.